These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9412416)

  • 21. Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection.
    Lau SM; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2004 Jun; 37(3):185-91. PubMed ID: 15221039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gram-negative bacterial resistance to cephalosporins in community-acquired infections in Turkey.
    Erdem H; Kiliç S; Pahsa A; Besirbellioglu
    J Chemother; 2005 Feb; 17(1):61-5. PubMed ID: 15828445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fluoroquinolone and aminoglycoside resistance in chromosomal cephalosporinase-overproducing gram-negative bacilli strains with inducible beta-lactamase].
    López-Yeste M; Xercavins M; Lite J; Cuchí E; Garau J
    Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):211-4. PubMed ID: 9044634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary pathogens and bacterial sensitivity in hospitalized urological patients based upon clinical aspects.
    Naber KG; Bauernfeind A; Dietlein G; Wittenberger R
    Scand J Urol Nephrol Suppl; 1987; 104():47-57. PubMed ID: 3501901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.
    Bonsu BK; Shuler L; Sawicki L; Dorst P; Cohen DM
    Acad Emerg Med; 2006 Jan; 13(1):76-81. PubMed ID: 16365328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The structure and antibiotic sensitivity of the causative agents of community-acquired infectious diseases of bacterial origin in children].
    Samsygina GA; Dudina TA; Korniushin MA; Ovechkina NV
    Antibiot Khimioter; 2000; 45(3):15-9. PubMed ID: 10768061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of microbiological monitoring of infective agents in an urological hospital in the selection of antibacterial therapy regimens].
    Derevianko II; Nefedova LA; Lavrinova LN; Prudnikova SA
    Urologiia; 2001; (4):11-5. PubMed ID: 11569227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative analysis of the structure and antibiotic sensitivity of the gram-negative causative agents of suppurative-inflammatory diseases in the patients of a surgical and urological hospital].
    Bekbergenov BM; Speranskaia ON; Gel'fand BR; Ukhin AV; Topazova EN
    Antibiot Med Biotekhnol; 1986 Mar; 31(3):220-4. PubMed ID: 3717920
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance and characterisation of pseudomonads from urinary tract specimens.
    Taneja N; Meharwal SK; Sharma SK; Sharma M
    J Commun Dis; 2004 Mar; 36(1):27-34. PubMed ID: 16295683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of lomefloxacin in treatment of nonspecific inflammatory diseases and in prophylaxis of postoperative complications in urology].
    Derevianko II; Khodyreva LA; Avdoshin VL; Andriukhin MI; Gabliia MIu
    Antibiot Khimioter; 1998; 43(10):36-41. PubMed ID: 9825109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing pattern of antimicrobial susceptibility of organisms causing community acquired urinary tract infections.
    Farooqi BJ; Shareeq F; Rizvi QK; Qureshi HS; Ashfaq MK
    J Pak Med Assoc; 2000 Nov; 50(11):369-73. PubMed ID: 11126812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ANTIBIOTIC RESISTANCE PATTERNS OF URINARY TRACT INFECTIONS IN A NORTHEASTERN BRAZILIAN CAPITAL.
    Cunha MA; Assunção GL; Medeiros IM; Freitas MR
    Rev Inst Med Trop Sao Paulo; 2016; 58():2. PubMed ID: 26910446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
    Nikodemski T
    Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul.
    Tariq TM
    J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia.
    Assefa A; Asrat D; Woldeamanuel Y; G/Hiwot Y; Abdella A; Melesse T
    Ethiop Med J; 2008 Jul; 46(3):227-35. PubMed ID: 19271386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary tract infection and drug-resistant bacteria in different patient populations.
    Nitzan Y; Maayan M; Wajsman C; Drucker M
    Isr J Med Sci; 1983 Dec; 19(12):1039-45. PubMed ID: 6363352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of the study on antibiotic resistance emergence among pathogens of community-acquired urinary tract infections in Moscow. Phase I].
    Sidorenko SV; Ivanov DV
    Antibiot Khimioter; 2005; 50(1):3-10. PubMed ID: 16302640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.